Search Results 151-160 of 28436 for B cell lymphomas

  1. Lymphoma - Doctors and departments - Mayo Clinic

    Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...

  2. Hematology - Clinical trials

    Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...

  3. A Study Of Durvalumab In Combination With R-CHOP Or Lenalidomide Plus R-CHOP In Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    CD20+Diffuse Large B-Cell Lymphoma. · Ann Arbor stage 3 or 4 or stage 2 with bulky disease · High or high-intermediate disease risk. · No prior anti-lymphoma ...

  4. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

    ... B-cell lymphoma, Acute myelogenous leukemia, Non-Hodgkin lymphoma, Burkitt lymphoma, T-cell lymphoma, Follicular lymphoma, Hodgkin lymphoma ...

  5. Hematology - Clinical trials

    ... B-cell and T-cell lymphomas. Testing Whether High Dose Chemotherapy And Infusion Of The Patients' Own Stem Cells Improves Survival In Patients With ...

  6. About CAR-T cell therapy - Mayo Clinic

    Aggressive B-cell lymphoma not otherwise specified (NOS); Mantle cell lymphoma; Follicular lymphoma; Multiple myeloma. People who have relapsed or refractory ...

  7. Study Of Pembrolizumab (MK-3475) In Participants With Relapsed Or Refractory Primary Mediastinal Large B-cell Lymphoma Or Relapsed Or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

    About this study. In this study, participants with relapsed or refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory ...

  8. A Phase I/II Study Of AZD4512 Monotherapy Or In Combination With Anticancer Agents In Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell Non-Hodgkin Lymphoma (B-NHL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  9. Lymphoma - Survival rates - Mayo Clinic

    Incorporation of digital gene expression profiling for cell-of-origin determination (Lymph2Cx Testing) into the routine work-up of diffuse large B-cell lymphoma ...

  10. Andrew L. Feldman, M.D. - Mayo Clinic Faculty Profiles

    ... B-cell lymphoma, T-cell lymphomas remain relatively understudied. Dr ... cell lymphoma and the biologic consequences of these abnormalities in the tumor cells.